Drug Shortage Report for FASTURTEC

Last updated on 2020-03-05 History
Report ID 103021
Drug Identification Number 02248416
Brand name FASTURTEC
Common or Proper name Fasturtec
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) RASBURICASE
Strength(s) 1.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 3
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-02-03
Actual start date
Estimated end date 2020-03-06
Actual end date 2020-03-04
Shortage status Resolved
Updated date 2020-03-05
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-03-05 English Compare
v8 2020-03-04 French Compare
v7 2020-03-04 English Compare
v6 2020-03-04 English Compare
v5 2020-03-02 French Compare
v4 2020-03-02 English Compare
v3 2020-02-04 English Compare
v2 2020-01-10 French Compare
v1 2020-01-10 English Compare